| |
1 2 3 4 5 6 7 8
читать далее ... 117 (2), 77-78 17 Qualmann С , Nauck M et al Glucagon-hke peptide I (7-36 amide) secretion in response to lummal sucrose from the upper and lower gut A study using alphaglucosidase inhibition (acarbose) Scand J Gastroenterol , 1995, 30 (9), 892-896 18 Meneilly G , Greig N et al Effects of 3 months of continuous administration of glucagons like peptide 1 in elderly patients with type 2 diabetes Diabetes Care, 2003, 26 (10), 2835-2841 19 Nikolaidis L, Mankad S , Sokos G et al Effects of glucagons-like peptide-1 in patients with acute myocardial mfarction and left ventncular dysfunction after successful reperfusion Circulation 2004 109, 962-965 20 Koya D King G Protein kinase С activation and the development of diabetic complications Diabetes, 1998, 47 (6). 859-866 21 Соколов Е И Сахарный диабет и атеросклероз, M Наука, 1996 22 Zilversrmt D Atherogenesis a postprandial phenomenon Circulation, 1979, 60 (3), 473-485 23 Перова Н В , Бубнова М Г , Аронов ДМ и др Влияние ловастатина на концентрацию липидов и липопротеидов в сыворотке крови после алиментарнои жировой нагрузки у больных ИБС Кардиология, 1996, 3 47-53 24 Kado S Murakamr N et al Effect of acarbose on postprandial lipid metabolism in type 2 diabetes melhtus Diabetes Res Chn Pract , 1998, 41 (1), 49-55 25 Maruhdina Y Sasaki M et al Wirksamkeit von acarbose auf hipennsulmamie und hyperlipidarme bei ubergewicht Krso fo Rinsno 1995, 20, 172-180 26 Chiasson J -L Acarbose for prevention of type 2 diabetes mellitus the STOPNIDDM randomized trial Lancet, 2002, 359, 2072-2077 27 Аронов Д М Лечение и профилактика атеросклероза, М, Триада-Х, 2000, 411 стр 28 Hanefeld M , Chiasson J , Koehler С et al Acarbose slows progression of intimamedia thickness of the carotid arteries in subjects with impaired glucose tolerance Stroke, 2004, 1073-1078 29 Cenello A, Taboga С , Tonutti L et al Postmeal coagulation in diabetes melhtus the effect ofacarbose Diabetologia, 1996, 39. 469-473 30 Mertes G Safety and efficacy of acarbose in the treatment of type 2 diabetes data from a 5-year survellance study Diabetes Res Chn Pract, 2001, 52 (3) 193-204 31 Hanefeld M Cagatay M Acarbose reduces the nsk for myocardial mfarction in type 2 diabetic patients meta-analysis of seven long-term studies Eur Heart J , 2004, 1, 10-16Источник: Аронов Д.М. Клиническая фармакология и терапия. 2004. №4. С.26-30
|
| | |
|
